Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
239,381
-
Share change
-
+232,481
-
Total reported value
-
$6,677,000
-
Price per share
-
$27.17
-
Number of holders
-
4
-
Value change
-
+$6,318,000
-
Number of buys
-
3
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q2 2019
As of 30 Jun 2019,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
239,381 shares.
The largest 4 holders included
BlackRock Inc., JANE STREET GROUP, LLC, CWM, LLC, and UBS Group AG.
This page lists
4
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.